![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
|
|||||||||
Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual |
| Chronic Renal Failure |
|
Free Subscription
1 Am J Nephrol |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Chronic Renal Failure is free of charge.
Trends and Independent Correlates of Chronic Kidney Disease Awareness in United
States Adults: NHANES 1999-2020.
Am J Nephrol. 2025 Nov 7:1-14. doi: 10.1159/000549324.
PubMed
Abstract available
Analysis of risk factors related to osteoporosis in maintenance hemodialysis
patients.
Clin Nephrol. 2025 Nov 10. doi: 10.5414/CN111686.
PubMed
Abstract available
Artificial intelligence in kidney disease and dialysis: from data mining to
clinical impact.
Curr Opin Nephrol Hypertens. 2025 Nov 10. doi: 10.1097/MNH.0000000000001132.
PubMed
Abstract available
Super high-flux membrane dialyzers and mortality in patients undergoing
hemodialysis.
Curr Opin Nephrol Hypertens. 2025 Nov 11. doi: 10.1097/MNH.0000000000001134.
PubMed
Abstract available
From Progression to Remission: A New Paradigm for Success in Chronic Kidney
Disease.
Kidney Int. 2025 Nov 6:S0085-2538(25)00847-6. doi: 10.1016/j.kint.2025.
PubMed
Abstract available
Balcinrenone in combination with dapagliflozin compared with dapagliflozin alone
in patients with chronic kidney disease and albuminuria: a randomised,
active-controlled double-blind, phase 2b clinical trial.
Lancet. 2025 Nov 8:S0140-6736(25)02014-8. doi: 10.1016/S0140-6736(25)02014.
PubMed
Abstract available
Augmenting nephroprotection: balcinrenone plus dapagliflozin in chronic kidney
disease.
Lancet. 2025 Nov 8:S0140-6736(25)02126-9. doi: 10.1016/S0140-6736(25)02126.
PubMed
Global, regional, and national burden of chronic kidney disease in adults,
1990-2023, and its attributable risk factors: a systematic analysis for the
Global Burden of Disease Study 2023.
Lancet. 2025 Nov 7:S0140-6736(25)01853-7. doi: 10.1016/S0140-6736(25)01853.
PubMed
Abstract available
Troxerutin is a novel osmotic agent for peritoneal dialysis with protective
cardiovascular actions.
Nephrol Dial Transplant. 2025 Nov 13:gfaf249. doi: 10.1093.
PubMed
Abstract available
Body roundness index and mortality risk in patients with chronic kidney disease:
moving beyond the obesity paradox.
Nephrol Dial Transplant. 2025 Nov 8:gfaf237. doi: 10.1093.
PubMed
Abstract available
Neurodevelopmental outcomes in children with chronic kidney disease: a scoping
review.
Pediatr Nephrol. 2025 Nov 12. doi: 10.1007/s00467-025-07017.
PubMed
Abstract available
Dyslipidaemia and inflammation are risks for subclinical atherosclerotic vascular
disease among chronic kidney failure patients in South Africa.
PLoS One. 2025;20:e0323882.
PubMed
Abstract available
Pre-dialysis medical social worker support and survival in patients with kidney
failure: impact on unplanned dialysis, hospitalization, and prognosis.
Ren Fail. 2025;47:2578417.
PubMed
Abstract available
Gut microbiota-derived TMAO drives the kidney-bone-vascular axis in chronic
kidney disease complications.
Ren Fail. 2025;47:2575434.
PubMed
Abstract available
Genetic and metabolomic pathways linking frailty, chronic kidney disease, and
kidney failure: a Mendelian randomization and multi-omics analysis.
Ren Fail. 2025;47:2584751.
PubMed
Abstract available
Sustained low-efficiency dialysis-an old method but possibly a new solution for
environmental nephrology.
Ren Fail. 2025;47:2580065.
PubMed
Abstract available
Challenges in Management of BK Virus Infections in HIV-Infected Renal Transplant
Recipients.
Transplant Proc. 2025 Nov 12:S0041-1345(25)00536.
PubMed
Abstract available
Thank you for your interest in scientific medicine.